An in-depth report from the 7th Annual Meeting of the International Publication Planning Association (TIPPA) held in San Francisco, CA, USA, 15-16 June 2009. Written by Elizabeth (Liz) Wager.
Product Details - See below for further product information
Note the document you buy is licensed for your own use only.
Our Price: £75.00 You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.
Related Products:
People who purchased this also purchased...
Further Product Information
Sample Pages sample pages .
CONTENTS Programme About the author Current challenges in publication planning The FDA Amendments Act Risk mitigation in publication planning Doing more with less Coping with a global organisation Clinical trial disclosure requirements Generating and communicating economic and humanistic value to payers and decision makers Editors’ panel Senate Finance Committee inquiries GPP and GPP2 Tackling the authorship debate Reprints and supplements Publication and reporting bias Firewalls: responding to the current regulatory environment The TIPPA member survey Conclusions ReferencesABOUT THE AUTHOR Getting Research Published: An A to Z of Publication Strategy and How to Survive Peer Review . She is a co-author of Good Publication Practice For Pharmaceutical Companies and the European Medical Writers Association guidelines on the role of medical writers.BMJ ’s Ethics Committee, the World Association of Medical Editors Ethics Committee, and the World Health Organization Scientific Advisory Group on trial registration. She is also a Visiting Fellow at the UK Cochrane Centre.EXECUTIVE SUMMARY PROGRAMME DAY ONE FDAAA, Efficiency & Accelerated Time Lines: How Does it All Add Up? Risk Mitigation in Publication Planning: How to Proactively Face the Industry’s Newest Challenges Doing More with Less: How Publication Planners Can Maintain (& Improve) Fiscal Support from Senior Management Coping with a Global Organization: The Pros & Cons of the Most Popular Models The Changing Healthcare Environment: Generating & Communicating Economic & Humanistic Value to Payers & Decision Makers Clinical Trial Disclosures: Hot Button Issues & the Latest Updates The Editors’ Perspective: Promoting a More Effective Partnership between Publication Planners and Journals DAY TWO Senate Finance Program for Medical Publication Professionals What You Need to Know About GPP2: Updates and Implications for Publication Planners Tackling the Authorship Debate: A Practical Discussion on Disclosure, Transparency & Positive Steps You Can Take to Move Beyond the Guidelines Reviews, Reprints & Supplements: Demystifying the Current Environment Publication and Reporting Bias of Clinical Trials Submitted to the FDA Firewalls: How do we Reorganize and Conduct Business to Respond to the Current Environment?
